← Back to Search

Sleep for Sleep Deprivation

N/A
Recruiting
Led By Philip Millar
Research Sponsored by University of Guelph
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the introductory visit and during each familiarization visit and testing visit (5 time points total)
Awards & highlights

Study Summary

This trial looks at whether habitual sleep patterns predict performance on a 20-min time trial after partial sleep deprivation in healthy cyclists, 18-50 years old, and if sleep deprivation affects blood pressure, heart rate, and metabolic responses.

Who is the study for?
This trial is for healthy individuals aged 18-50, who are non-smokers, not on chronic medication (except oral contraceptives), and without cardiovascular or sleep disorders. They should be able to engage in physical activity and follow the sleep protocols of the study. Pregnant individuals or those allergic to ultrasound gel cannot participate.Check my eligibility
What is being tested?
The study tests how habitual sleeping patterns affect endurance performance after a night of partial sleep deprivation in cyclists. It examines changes in blood pressure, heart rate, metabolic responses during exercise, and vascular function under normal sleep and deprived conditions using an ActiGraph device.See study design
What are the potential side effects?
Since this trial involves monitoring natural behaviors like sleeping habits rather than testing a drug or medical intervention, there are no direct side effects from treatments being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the introductory visit and during each familiarization visit and testing visit (5 time points total)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the introductory visit and during each familiarization visit and testing visit (5 time points total) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance
Secondary outcome measures
Flow-mediated dilation
Other outcome measures
Carbon dioxide production during exercise
Carbon dioxide production during recovery
Gross efficiency during exercise
+8 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Sleep deprivationActive Control1 Intervention
Participants will be asked to go to bed normally but wake up earlier, such that normal sleep duration is restricted by 60%. For example, if someone normally sleeps for 8 hours by falling asleep at 11 pm and waking up at 7 am, they will be asked to fall asleep normally (11 pm) and sleep for 3.2 hours, which results in a wake-up time of 2:12 am.
Group II: Normal sleepPlacebo Group1 Intervention
Participants will be asked to sleep during their normal sleep times prior to this visit

Find a Location

Who is running the clinical trial?

University of GuelphLead Sponsor
81 Previous Clinical Trials
14,926 Total Patients Enrolled
Philip MillarPrincipal InvestigatorUniversity of Guelph

Media Library

Sleep deprivation Clinical Trial Eligibility Overview. Trial Name: NCT05942664 — N/A
Hemodynamics Research Study Groups: Sleep deprivation, Normal sleep
Hemodynamics Clinical Trial 2023: Sleep deprivation Highlights & Side Effects. Trial Name: NCT05942664 — N/A
Sleep deprivation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05942664 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any criteria that must be met to join this research project?

"The criteria for enrollment in this trial necessitates that all participants are aged between 18 and 50 years old, with a healthy amount of sleep. In total, 20 people need to be recruited into the study."

Answered by AI

Is there still availability for participants in this research?

"Clinicaltrials.gov confirms that this medical experiment is actively recruiting, with its original posting on June 26th 2023 and most recent update occurring on July 5th 2023."

Answered by AI

How many participants are taking part in this trial?

"Confirmed, the trial is either currently enrolling or soon will be. This study was first posted on June 26th 2023 and has been updated recently on July 5th 2023. It requires twenty participants to sign up at one facility."

Answered by AI

Does this trial have an upper age limit for enrollment?

"This medical study is open to persons aged 18 and over, up until the age of 50."

Answered by AI
~4 spots leftby Aug 2024